NYSE$ASIX
Advansix Inc · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
AdvanSix reported Q2 2025 results with sales of $410 million and EPS of $1.15.
AdvanSix Inc. announced its second quarter 2025 financial results on August 1, 2025, showing resilient performance amid softer demand in nylon markets. Sales declined 10% year-over-year to $410 million, while net income was $31.4 million and adjusted EPS reached $1.24, supported by $8 million in 45Q tax credits. Cash flow from operations was $21 million with sequential improvement driven by Plant Nutrients strength.
- Q2 2025 sales totaled $410 million, down 10% from $453 million in Q2 2024 due to lower volumes and pricing.
- Diluted EPS of $1.15 and adjusted EPS of $1.24, with adjusted EBITDA at $55.7 million (13.6% margin).
- Plant Nutrients segment revenue rose to $157 million (38% of total), while Nylon and Caprolactam declined.
- Free cash flow was negative $7.2 million after $28.3 million in capital expenditures; outlook highlights nylon cycle challenges and capex guidance of $135-145 million for 2025.
Headline financials
Revenue & EPS history
Advansix · Revenue · Quarterly
$410M
Revenue by segment
Advansix · $410M total across 4 segments · Q2 2025
- Plant Nutrients$157M—38.2%
- Chemical Intermediates$107M—26.2%
- Nylon$79.5M—19.4%
- Caprolactam$66.4M—16.2%
Forward guidance
Company anticipates higher ammonium sulfate pricing in 3Q25 YoY but typical seasonality; acetone spreads near cycle averages; navigating nylon downturn; 2025 capex $135-145 million and plant turnaround impact $25-30 million pre-tax.
Tailwinds
- Strong fall fill program at higher pricing for ammonium sulfate
- Acetone pricing remains near cycle averages
- Reduced plant turnaround impact vs 2024
Headwinds
- Extended downturn in nylon cycle
- Sequential domestic pricing decline expected in 3Q25 due to seasonality
- Lower acetone spread YoY
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
-0.8%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.6%
Avg return
30 days after
52%
23 / 44 earnings
Positive
+15.6%
Q1 2016
Best reaction
-15.5%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -14.5% | -6.0% | -9.9% | |
| Q4 2025 | +3.9% | +0.8% | +12.5% | |
| Q3 2025 | -15.0% | -10.9% | -11.7% | |
| Q1 2025 | +6.1% | +6.9% | +10.4% | |
| Q3 2024 | +5.0% | +11.8% | +14.5% | |
| Q2 2024 | +2.7% | +4.0% | +10.5% | |
| Q1 2024 | -9.9% | -6.3% | -8.0% | |
| Q4 2023 | +0.8% | -0.6% | -4.2% | |
| Q3 2023 | -9.5% | -13.2% | -5.0% | |
| Q2 2023 | -8.1% | -5.3% | -14.0% | |
| Q1 2023 | -0.7% | -1.2% | +1.1% | |
| Q4 2022 | -3.3% | -0.9% | -17.7% | |
| Q3 2022 | +3.7% | +1.7% | +14.9% | |
| Q2 2022 | +1.6% | +2.0% | -8.2% | |
| Q1 2022 | -3.9% | -4.2% | -2.2% | |
| Q4 2021 | -11.0% | -14.7% | +30.5% | |
| Q3 2021 | +5.4% | +8.3% | +2.4% | |
| Q2 2021 | +2.6% | +6.9% | +11.5% | |
| Q1 2021 | +3.3% | +6.7% | +3.4% | |
| Q4 2020 | +11.5% | +8.1% | +2.8% | |
| Q3 2020 | +4.4% | -1.3% | +23.6% | |
| Q2 2020 | +1.5% | +5.2% | +16.4% | |
| Q1 2020 | -6.0% | -7.2% | -2.8% | |
| Q4 2019 | -15.5% | -27.0% | -34.1% | |
| Q3 2019 | +3.4% | +4.0% | -11.1% | |
| Q2 2019 | -2.3% | -10.3% | -12.9% | |
| Q1 2019 | +8.1% | +1.6% | -18.7% | |
| Q4 2018 | +2.0% | -1.2% | -15.6% | |
| Q3 2018 | -8.9% | -2.9% | -2.5% | |
| Q2 2018 | -13.2% | -13.5% | -15.0% | |
| Q1 2018 | -5.5% | +2.0% | +2.9% | |
| Q4 2017 | +4.5% | +6.6% | -12.2% | |
| Q3 2017 | -6.7% | -7.2% | -11.4% | |
| Q2 2017 | -4.6% | -4.0% | +3.2% | |
| Q2 2016 | -4.6% | -4.0% | +3.2% | |
| Q1 2017 | +15.6% | +13.7% | +11.3% | |
| Q1 2016 | +15.6% | +13.7% | +11.3% | |
| Q1 2015 | -7.1% | -9.9% | -11.7% | |
| Q2 2015 | -7.1% | -9.9% | -11.7% | |
| Q4 2014 | -7.1% | -9.9% | -11.7% | |
| Q4 2016 | +1.3% | -2.2% | +1.3% | |
| Q4 2015 | +8.5% | +6.9% | +30.4% | |
| Q3 2016 | +8.5% | +6.9% | +30.4% | |
| Q3 2015 | +8.5% | +6.9% | +30.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro